DIFFUSE MESANGIAL SCLEROSIS

This adverse event was reported 14 times

These drugs are most commonly taken by patients reporting DIFFUSE MESANGIAL SCLEROSIS:

# Drug Count
0 METHYLPREDNISOLONE 6
1 BASILIXIMAB 5
2 MYCOPHENOLATE MOFETIL 5
3 TACROLIMUS 5
4 TACROLIMUS CAPSULES 5
5 PREDNISOLONE 4
6 BELATACEPT 3
7 METHYLPREDNISOLONE SODIUM SUCCINATE 3
8 POSACONAZOLE 3
9 ALLOPURINOL 2
See all common drugs associated with DIFFUSE MESANGIAL SCLEROSIS

DIFFUSE MESANGIAL SCLEROSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 METOPROLOL SUCCINATE AND HYDROCHLOROTHIAZIDE 1 0.0256
1 BETAINE 1 0.0014
2 BELATACEPT 3 0.0011
3 ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE 1 0.0008
4 LEVOCARNITINE ORAL SOLUTION 1 0.0007
5 BASILIXIMAB 5 0.0006
6 LEVOCARNITINE 1 0.0005
7 AMPICILLIN INJECTION 2 0.0004
8 HYDROXOCOBALAMIN 1 0.0004
9 AMPICILLIN SODIUM 2 0.0003
See all drugs enriched for association with DIFFUSE MESANGIAL SCLEROSIS

DIFFUSE MESANGIAL SCLEROSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Methylating Agent [EPC] 1 0.0013
1 Selective T Cell Costimulation Blocker [EPC] 3 0.0011
2 Interleukin-2 Receptor Blocking Antibody [EPC] 5 0.0006
3 Carnitine Analog [EPC] 1 0.0005
4 Lipid-based Polyene Antifungal [EPC] 2 0.0002
5 Cephalosporin Antibacterial [EPC] 1 0.0002
6 Antidote [EPC] 1 0.0001
7 Polyene Antifungal [EPC] 2 0.0001
8 Vitamin D3 Analog [EPC] 1 0.0001
9 Alkaloid [EPC] 1 0.0001
See all drug classes enriched for association with DIFFUSE MESANGIAL SCLEROSIS